Do Proton Pump Inhibitors Cause Zinc Deficiency?
Long-term proton pump inhibitor use is associated with lower zinc levels and with a much weaker response to zinc supplements. In this small human study, adults with gastroesophageal reflux disease who had taken a PPI daily for more than six months had 28% lower plasma zinc than healthy people taking no acid-suppressing medication, and when both groups took the same zinc supplement, the PPI group’s plasma zinc barely moved by comparison.
Dr. Kumar’s Take
This is a small human study, not a large trial, and it compares PPI users with healthy volunteers rather than randomizing anyone, so I read it as a signal rather than proof. But the signal is a clean one: the same supplement produced a large rise in plasma zinc in people making stomach acid and a small rise in people whose acid was being suppressed. That matters to me because the usual clinical reflex, when a patient on a PPI has a low micronutrient level, is to add a supplement and move on. If acid is the step that makes the mineral absorbable, adding more of it by mouth is not a reliable fix. Zinc matters for immune function, wound healing, growth in children, and taste, and those are the kinds of complaints that get attributed to almost anything before anyone looks at the acid-blocking prescription.
What the Research Shows
The investigators studied two groups of people: patients with gastroesophageal reflux disease on long-term PPI therapy, meaning more than six months, and healthy test subjects taking no acid-preventing or acid-neutralizing medication. Both groups took oral zinc gluconate, 26.2 mg of zinc twice daily, for 14 days. Venous blood was then drawn and the plasma analyzed for total zinc by atomic absorption spectrophotometry. Baseline plasma and red blood cell zinc were also measured in both groups while they were taking no zinc supplement at all.
Over the supplementation period, plasma zinc in the healthy controls rose 126%. In the long-term PPI users it rose 37%. Off supplements, on their normal diet, the PPI users’ plasma zinc sat 28% below that of the healthy controls, with a p value below 0.005.
The authors conclude that PPI use dramatically reduces uptake of supplemental zinc and can result in decreased zinc body stores. They single out one group as a particular concern: people kept on long-term PPI therapy who have high developmental, regenerative, and immunological demands, including infants treated for colic.
How This Works (Biological Rationale)
PPIs irreversibly deactivate the hydrogen-potassium ATPase on the luminal side of the parietal cell membrane. That raises gastroduodenal luminal pH from roughly 1.5 to roughly 6.0. Zinc has been reported to be readily absorbed at low pH and much less readily at elevated pH, so raising the pH of the compartment where absorption happens is a plausible route to the effect measured here.
This is the same logic already applied to other nutrients that depend on stomach acid. Acid helps dissociate iron from food and reduces it to a more soluble form for uptake by the intestinal mucosa. Acid is also required to release vitamin B12 from ingested proteins. Zinc, like calcium and magnesium, is a divalent cation, and the hypochlorhydria that has been shown to reduce calcium and magnesium absorption in the duodenum could reasonably do the same to zinc. Before this study, PPI-mediated depletion of zinc body stores had not been reported or investigated.
Results in Real Numbers
- Response to a zinc supplement, healthy controls: plasma zinc rose 126%
- Response to the same supplement, long-term PPI users: plasma zinc rose 37%
- Baseline plasma zinc, no supplement, normal diet: 28% lower in PPI users than in healthy controls, p < 0.005
- Supplement tested: zinc gluconate, 26.2 mg of zinc, twice daily for 14 days
- PPI exposure defining “long-term”: daily therapy for more than six months
- Gastroduodenal luminal pH on PPI therapy: rises from about 1.5 to about 6.0
Safety, Limits, and Caveats
This was a small study comparing two groups that differ in more than their medication: one had gastroesophageal reflux disease and one was healthy. That design cannot separate the effect of the drug from the effect of the condition or the diet and habits that go with it. Plasma zinc is also an imperfect proxy for total body zinc stores.
Zinc supplementation is not risk-free at the other end either. The most worrisome complication of zinc excess is copper depletion, which can cause anemia, nerve damage, and bone loss. That is a real reason not to treat “on a PPI” as an automatic prescription for high-dose zinc.
Worth keeping in view: PPIs are a heavily used class, with 110 million prescriptions written in the United States in 2009, making them the third largest class of drug prescribed in the country. A modest per-person effect in a class that widely used is not a small matter, but it also does not mean any individual patient is deficient.
Practical Takeaways
- If you take a PPI daily and long term, zinc status is a reasonable thing to discuss with your doctor rather than assume is fine.
- Do not assume a zinc supplement solves the problem while acid suppression continues. In this study the same dose produced a much smaller plasma rise in PPI users than in controls.
- Use the lowest effective PPI dose for the shortest duration that controls symptoms, and revisit whether the prescription is still needed.
- Watch for the clinical picture of zinc deficiency described in the literature the authors cite: poor appetite, taste abnormalities, delayed wound healing, skin changes, mental lethargy, and in children and adolescents, growth retardation.
- Be cautious about high-dose zinc taken indefinitely without supervision, given the risk of copper depletion.
- Give particular thought to infants and children maintained on long-term acid suppression, the group the authors flag directly.
Related Studies and Research
- Use of Proton Pump Inhibitors and Risk of Iron Deficiency: Population-Based Study
- Proton Pump Inhibitors and Hypomagnesemia
- Vitamin B12 Intake From Animal Foods, Biomarkers, and Health Aspects
- Pharmacology of Proton Pump Inhibitors
- Episode 25: The Great GERD Mistake - How Medicine Made Heartburn Worse and How to Fix It
FAQs
How do PPIs affect zinc absorption?
PPIs shut down the gastric proton pump and raise gastroduodenal pH from about 1.5 to about 6.0. Zinc is reported to be readily absorbed at low pH and much less so at elevated pH, so the acid suppression removes the conditions that favor its uptake.
Does taking a zinc supplement fix the problem while I stay on a PPI?
Not to the same degree. On an identical 14-day course of zinc gluconate at 26.2 mg twice daily, plasma zinc rose 126% in healthy controls but only 37% in long-term PPI users.
What are the symptoms of zinc deficiency I should watch for?
The deficiency picture described in the literature the authors cite includes poor appetite, taste abnormalities, delayed wound healing, skin changes, mental lethargy, anergy, growth retardation in children and adolescents, and hypogonadism in men.
How long had the PPI users in this study been taking the drug?
More than six months of daily therapy. That was the threshold the investigators used to define long-term use.
Is there a downside to taking zinc?
Yes. The most worrisome complication of zinc excess is copper depletion, which can lead to anemia, nerve damage, and bone loss. Dose and duration are worth deciding with your doctor rather than on your own.
Bottom Line
In this small human study, long-term PPI users had plasma zinc 28% lower than healthy controls and got far less benefit from an oral zinc supplement: a 37% rise versus 126% in controls. The authors conclude that PPI use dramatically reduces supplemental zinc uptake and can lower zinc body stores, and they flag people kept on long-term acid suppression, including infants treated for colic, as the group most worth watching.
